MX2022001349A - Metodos para purificar anticuerpos. - Google Patents

Metodos para purificar anticuerpos.

Info

Publication number
MX2022001349A
MX2022001349A MX2022001349A MX2022001349A MX2022001349A MX 2022001349 A MX2022001349 A MX 2022001349A MX 2022001349 A MX2022001349 A MX 2022001349A MX 2022001349 A MX2022001349 A MX 2022001349A MX 2022001349 A MX2022001349 A MX 2022001349A
Authority
MX
Mexico
Prior art keywords
methods
recombinant antibody
purifying antibodies
imidazole
purifying
Prior art date
Application number
MX2022001349A
Other languages
English (en)
Inventor
Neil Alan Watson
Curtis William Phippen
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Publication of MX2022001349A publication Critical patent/MX2022001349A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/38—Flow patterns
    • G01N2030/381—Flow patterns centrifugal chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins

Abstract

La presente invención se refiere al campo de la producción de moléculas de anticuerpos recombinantes. En particular, se proporcionan métodos para purificar tales moléculas de anticuerpo recombinante en las que se agrega imidazol o un análogo de imidazol durante la elución de la molécula de anticuerpo recombinante a partir de una resina de cromatografía de afinidad, tal como una resina basada en proteína A.
MX2022001349A 2019-08-02 2020-07-30 Metodos para purificar anticuerpos. MX2022001349A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19189841 2019-08-02
PCT/EP2020/071533 WO2021023619A1 (en) 2019-08-02 2020-07-30 Methods for purifying antibodies

Publications (1)

Publication Number Publication Date
MX2022001349A true MX2022001349A (es) 2022-03-25

Family

ID=67658409

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022001349A MX2022001349A (es) 2019-08-02 2020-07-30 Metodos para purificar anticuerpos.

Country Status (13)

Country Link
US (1) US20220280887A1 (es)
EP (1) EP4007771A1 (es)
JP (1) JP2022543187A (es)
KR (1) KR20220039744A (es)
CN (1) CN114401984A (es)
AR (1) AR119546A1 (es)
AU (1) AU2020326087A1 (es)
BR (1) BR112021023542A2 (es)
CA (1) CA3142610A1 (es)
IL (1) IL289959A (es)
MX (1) MX2022001349A (es)
SG (1) SG11202112846RA (es)
WO (1) WO2021023619A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230092867A1 (en) * 2020-01-20 2023-03-23 WuXi Biologics Ireland Limited A novel wash buffer solution for affinity chromatography

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726293A (en) * 1992-10-02 1998-03-10 The General Hospital Corporation Affinity purification methods involving imidazole elution
US20040063153A1 (en) * 2002-08-12 2004-04-01 Tomas Jelinek Method for isolation of protein complexes using affinity binding
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
UA112203C2 (uk) 2011-11-11 2016-08-10 Юсб Фарма С.А. Злитий білок біоспецифічного антитіла, який зв'язується з ox40 людини та сироватковим альбуміном людини
CA2856216C (en) 2011-11-11 2021-01-12 Ucb Pharma S.A. Albumin binding antibodies and binding fragments thereof
GB201208370D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Antibodies
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
GB201411320D0 (en) 2014-06-25 2014-08-06 Ucb Biopharma Sprl Antibody construct
GB201506868D0 (en) 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method for protein purification

Also Published As

Publication number Publication date
JP2022543187A (ja) 2022-10-11
AR119546A1 (es) 2021-12-29
IL289959A (en) 2022-03-01
BR112021023542A2 (pt) 2022-03-22
EP4007771A1 (en) 2022-06-08
WO2021023619A1 (en) 2021-02-11
CA3142610A1 (en) 2021-02-11
CN114401984A (zh) 2022-04-26
US20220280887A1 (en) 2022-09-08
KR20220039744A (ko) 2022-03-29
SG11202112846RA (en) 2021-12-30
AU2020326087A1 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
MX355255B (es) Variantes de fc y métodos para su producción.
MX2012012119A (es) Produccion de proteinas heteromultimericas.
MX350610B (es) Proceso para la purificacion de anticuerpos monoclonales.
UA117575C2 (uk) Антитіло, яке специфічно зв'язується з il-17a та його застосування
EA201990321A1 (ru) Биспецифические антителоподобные связывающие белки, которые специфически связываются с cd3 и cd123
RU2016109322A (ru) Разделение биспецифических антител и побочных продуктов процесса получения биспецифических антител с применением гидроксиапатитной хроматографии
MX2021012251A (es) Metodo para purificar un anticuerpo modificado en la region de fragmento cristalizable (fc).
TW200716669A (en) Method for the purification of antibodies
MX2017004117A (es) Moleculas de enlace, especialmente anticuerpos, enlazadas a l1cam(cd171).
MX2020000288A (es) Cromatografia.
WO2018194496A3 (ru) Моноклональное антитело к pd-l1
MX2009008608A (es) Anticuerpos monoclonales anti-cxcl13.
EP2574631A4 (en) FILLER FOR AFFINITY CHROMATOGRAPHY AND METHOD FOR ISOLATING IMMUNE LOBULIN
MX2023006291A (es) Metodos para purificar proteinas que contienen fc.
MX2010004660A (es) NUEVOS ANTICUERPOS ESPECIFICOS DE LOS PEPTIDOS ß-AMILOIDES Y SUS USOS COMO AGENTES DE DIAGNOSTICO Y DROGAS.
MX2022002024A (es) Moleculas de union anti-cd123 multimericas biespecificas y usos de estas.
NZ781138A (en) Anti-vegf protein compositions and methods for producing the same
ATE529433T1 (de) Verfahren zur reinigung eines il-18-bindenden proteins
MX2021014334A (es) Agentes afines a aav9.
MX2022001349A (es) Metodos para purificar anticuerpos.
MX2021009275A (es) Moleculas de union especificas.
WO2018231339A3 (en) TYROSINE PHOSPHORYLATED ANTI-PD-1 ANTIBODIES AND USES THEREOF
KR20220079910A (ko) 숙주-세포 단백질을 특성화하는 방법
MX2021007028A (es) Anticuerpo anti-il-17a y uso del mismo.
EA202190459A1 (ru) Способ и хроматографическая система для определения количества и чистоты мультимерного белка